KRONİK LENFOSİTİK LÖSEMİ TEDAVİ PROTOKOLLERİ

Kaynaklar:

1- Fischer, K., O. Al-Sawaf, J. Bahlo, et al. 2019. “Venetoclax and obinutuzumab in patients with CLL and coexisting conditions.” N Engl J Med 380(23):2225-2236

2 - Tausch E Schneider C Robrecht S et al. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax. Blood. 2020; 135: 2402-2412

3-Flinn IW Gribben JG Dyer MJS et al. Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia. Blood. 2019; 133: 2765-2775.